Valuation dashboard for Health Catalyst, Inc. (HCAT) with P/E N/A, P/B 1.28, EV/EBITDA -1.25 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision.
Analysis Summary
Health Catalyst, Inc. reported revenue of $311.1M in the most recent fiscal year, growing at a 5-year CAGR of 10.5%.
Trailing-twelve-month margins: gross margin 46.4%, operating margin -19.7%, net margin -90.6%.
At the current price of $1.73, HCAT has negative trailing earnings (P/E not meaningful) and an ROE of -129.70%. Market capitalisation stands at $128M.
Balance sheet quality for HCAT: current ratio of 1.9. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 1.28 |
| EV / EBITDA | -1.25 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-11.54 |
| vs Current Price | -766.9% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| HCAT | Health Catalyst, Inc. | $128M | 1.28 | -129.7% | |
| TEM | Tempus AI, Inc. | $12.3B | 22.79 | -49.9% | |
| BTSG | BrightSpring Health Services, Inc. Common Stock | $11.6B | |||
| HQY | HealthEquity, Inc. | $8.1B | 34.54 | 4.05 | |
| HNGE | Hinge Health, Inc. | $7.3B | |||
| WAY | Waystar Holding Corp. | $5.1B | 34.57 | 1.20 | 3.6% |
| DOCS | Doximity, Inc. | $4.8B | 29.31 | 5.20 | |
| HTFL | Heartflow, Inc. Common Stock | $4.2B | 14.82 | -42.3% |
Price
| Price | $1.73 |
| Market Cap | $128M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -129.70% |
| Return on Invested Capital | -21.13% |
| Return on Assets | -73.85% |
| Gross Margin | 46.44% |
| Operating Margin | -19.67% |
| Net Margin | -90.61% |
Related companies: CRBU · ENTA · HSDT · NNOX · OBIO · OM · PRLD
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of HCAT: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks